There is no single test that is run to assess the safety, stability, and scalability of a biologic treatment. Instead, these key characteristics are measured using a variety of analytical and observational tests. In order to assess the biologic’s viability as a therapeutic, scientists must be able to analyze all of these data points in […]

Biopharmaceuticals are increasingly being prescribed for a variety of diseases, from autoimmune disorders such as arthritis to neurological conditions like Alzheimer’s. Neutralizing antibody (NAb) assays are a critical component of biopharmaceutical development, helping inform researchers of potential product efficacy and patient safety. Having reproducible, repeatable NAb assay results will improve the product research pipeline and […]